<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37073325</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.</ArticleTitle><Pagination><StartPage>101961</StartPage><MedlinePgn>101961</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101961</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2023.101961</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Adults and children can develop post-Covid-19 condition (PCC) (also referred to as Long Covid). However, existing evidence is scarce, partly due to a lack of a standardised case definition, short follow up duration, and heterogenous study designs, resulting in wide variation of reported outcomes. The primary aim of this study was to characterise risk factors for PCC and longitudinal rates of recovery in a cohort of children and young people using a standardised protocol.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We performed a prospective "disease-based" cohort study between 01/02/2020 to 31/10/2022 including children aged 0-18 years old, with a previous diagnosis of Covid-19. Children with microbiologically confirmed SARS-CoV-2 infection, were invited for an in-clinic follow-up assessment at a paediatric post-covid clinic in Rome, Italy, at serial intervals (3-, 6-, 12- and 18-months post-onset). PCC was defined as persistence of otherwise unexplained symptoms for at least three months after initial infection. The statistical association between categorical variables was obtained by Chi-squared tests or Fisher's exact tests. Multivariable logistic regressions are presented using odds ratios (OR) and 95% confidence interval (CI). Survival analysis was conducted using the Kaplan-Meier method.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">1243 children were included, median age: 7.5 (4-10.3) years old; 575 (46.3%) were females. Of these, 23% (294/1243) were diagnosed with PCC at three months post-onset. Among the study population, 143 patients remained symptomatic at six months, 38&#xa0;at 12 months, and 15&#xa0;at 18 months follow up evaluation. The following risk factors were associated with PCC: &gt;10 years of age (OR 1.23; 95% CI 1.18-1.28), comorbidities (OR 1.68; 95% CI 1.14-2.50), and hospitalisation during the acute phase (OR 4.80; 95%CI 1.91-12.1). Using multivariable logistic regression, compared to the Omicron variant, all other variants were significantly associated with PCC at 3 and 6 months. At least one dose of vaccine was associated with a reduced, but not statistically significant risk of developing PCC.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">In our study, acute-phase hospitalisation, pre-existing comorbidity, being infected with pre-Omicron variants and older age were associated with a higher risk of developing PCC. Most children recovered over time, but one-in-twenty of those with PCC at three months reported persistent symptoms 18 months post-Sars-CoV-2 infection. Omicron infection was associated with shorter recovery times. We did not find a strong protective effect of vaccination on PCC development. Although our cohort cannot be translated to all Italian children with PCC as more nationwide studies are needed, our findings highlight the need of new strategies to prevent and treat pediatric PCC are needed.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This study has been funded by Pfizer non-competitive grant, granted to DB (# 65925795).</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastrantoni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Oncology, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, I.M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care for Long Term Conditions Division, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ISARIC Global Support Centre, GloPID-R Research and Policy Team, Pandemic Sciences Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Post-covid condition</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Sars-CoV-2 variants</Keyword><Keyword MajorTopicYN="N">Sars-Cov-2 infection</Keyword></KeywordList><CoiStatement>DB was been granted a non-competitive grant from Pfizer to study PCC in children, and has won a grant to study mRNA profile in children with PCC from Roche Italia and ESPID. DB has participated in educational peer-to-peer programs on PCC organised by Pfiser and has participated as invited speaker and a sponsored session of Covid-19 vaccines in children at the ESPID conference in 2022. LS was supported by funding via ISARIC from the UK Foreign, Commonwealth &amp; Development Office, Wellcome (215091/Z/18/Z) and the Bill &amp; Melinda Gates Foundation (OPP1209135).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>1</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37073325</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pii">S2589-5370(23)00138-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) dashboard, 06-December-2022. 2022. https://covid19.who.int/ Available at:</Citation></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1, 2021</Citation></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136. Erratum in: BMJ. 2022J;376:o126. PMID: 33483331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Centres for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Fclinical-care%2Fpost-covid-index.html.</Citation></Reference><Reference><Citation>National Institute of Health, Long Covid, 2021. Available at: https://covid19.nih.gov/covid-19-topics/long-covid#:&#x223c;:text=Long%20COVID%2C%20long%2Dhaul%20COVID,of%20a%20COVID%2D19%20diagnosis.</Citation></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., et al. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107(7):674&#x2013;680. doi: 10.1136/archdischild-2021-323624. Epub 2022 Apr 1. PMID: 35365499; PMCID: PMC8983414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322(1):C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021. Epub 2021 Nov 24. PMID: 34817268; PMCID: PMC8721906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J&#xa0;Infect Dis. 2022;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136. PMID: 35429399; PMCID: PMC9047189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V., Gao M., West E.A., et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43 doi: 10.3389/phrs.2022.1604501. PMID: 35359614; PMCID: PMC8963488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R., Chiappini E., Licari A., Galli L., Marseglia G.L. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022:1&#x2013;15. doi: 10.1007/s00431-022-04600-x. Epub ahead of print. PMID: 36107254; PMCID: PMC9476461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. doi: 10.1038/s41598-022-13495-5. PMID: 35739136; PMCID: PMC9226045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Gennaro L., De Rose C., et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800. PMID: 35994282; PMCID: PMC9396470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19(11) doi: 10.1371/journal.pmed.1004122. PMID: 36355754; PMCID: PMC9648706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Parri N., De Rose C., Valentini P. Gemelli-pediatric COVID-19 team. Toward a clinically based classification of disease severity for paediatric COVID-19. Lancet Infect Dis. 2021;21(1):22. doi: 10.1016/S1473-3099(20)30396-0. Epub 2020 May 15. PMID: 32422205; PMCID: PMC7228718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30396-0</ArticleId><ArticleId IdType="pmc">PMC7228718</ArticleId><ArticleId IdType="pubmed">32422205</ArticleId></ArticleIdList></Reference><Reference><Citation>2022. https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-27-maggio-2022.pdf</Citation></Reference><Reference><Citation>Buonsenso D., Pazukhina E., Gentili C., et al. The prevalence, characteristics and risk factors of persistent symptoms in non-hospitalised and hospitalised children with SARS-CoV-2 infection followed-up for up to 12 months: a prospective, cohort study in Rome, Italy. J&#xa0;Clin Med. 2022;11:6772. doi: 10.3390/jcm11226772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11226772</ArticleId><ArticleId IdType="pmc">PMC9692851</ArticleId><ArticleId IdType="pubmed">36431250</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;j, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicentre study. J&#xa0;Clin Med. 2022;11(2):413. doi: 10.3390/jcm11020413. PMID: 35054108; PMCID: PMC8778106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002. Epub 2021 Nov 9. PMID: 34763058; PMCID: PMC8575536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R., Martino L., Buonsenso D. Diagnosis and management of post-COVID (Long COVID) in children: a moving target. Curr Opin Pediatr. 2023;35(2):184&#x2013;192. doi: 10.1097/MOP.0000000000001221. Epub 2023 Jan 23. PMID: 36660968; PMCID: PMC9994801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000001221</ArticleId><ArticleId IdType="pmc">PMC9994801</ArticleId><ArticleId IdType="pubmed">36660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino G.P., Benfaremo D., Bitti G., et al. 6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study. Intern Emerg Med. 2022;17(6):1641&#x2013;1649. doi: 10.1007/s11739-022-02979-x. Epub 2022 Apr 9. PMID: 35397762; PMCID: PMC8994524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-02979-x</ArticleId><ArticleId IdType="pmc">PMC8994524</ArticleId><ArticleId IdType="pubmed">35397762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani C., Borgonovo F., Capetti A.F., et al. Persistence of Long-COVID symptoms in a heterogenous prospective cohort. J&#xa0;Infect. 2022;84(5):722&#x2013;746. doi: 10.1016/j.jinf.2022.01.024. Epub 2022 Jan 22. PMID: 35077770; PMCID: PMC8783396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8783396</ArticleId><ArticleId IdType="pubmed">35077770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812. doi: 10.1038/s41467-022-29513-z. PMID: 35383197; PMCID: PMC8983754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati M., Nemati H. 'Long COVID': Symptom persistence in children hospitalised for COVID-19. J&#xa0;Paediatr Child Health. 2022;58(10):1836&#x2013;1840. doi: 10.1111/jpc.16120. Epub 2022 Jul 19. PMID: 35851732; PMCID: PMC9349535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.16120</ArticleId><ArticleId IdType="pmc">PMC9349535</ArticleId><ArticleId IdType="pubmed">35851732</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z. Epub 2022 Jan 9. PMID: 35000003; PMCID: PMC8742700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Morello R, Mariani F, De Rose C, Mastrantoni L, Zampino G, Valentini P. Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants. Acta Paediatr. 2023. 10.1111/apa.16764. Epub ahead of print. PMID: 36938946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16764</ArticleId><ArticleId IdType="pubmed">36938946</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2. PMID: 35717982; PMCID: PMC9212672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah S.E., Hao T., DeSantis S.M., et al. Comparison of persistent symptoms following SARS-CoV-2 infection by antibody status in nonhospitalised children and adolescents. Pediatr Infect Dis J. 2022;41(10):e409&#x2013;e417. doi: 10.1097/INF.0000000000003653. Epub 2022 Aug 1. PMID: 35939608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003653</ArticleId><ArticleId IdType="pubmed">35939608</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K., Kristoffersen D.T., Dell'Isola A., et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13:7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S., Tsuzuki S., Suzuki M., et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J&#xa0;Infect Chemother. 2022;28(11):1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007. Epub 2022 Aug 11. PMID: 35963600; PMCID: PMC9365517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatr. 2022;9(10):815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7. Epub 2022 Aug 17. PMID: 35987197; PMCID: PMC9385200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.M., Carter M.J., Ronny Cheung C., Ladhani S., Evelina PIMS-TS Study Group Lower risk of multisystem inflammatory syndrome in children (MIS-C) with the delta and omicron variants of SARS-CoV-2. Clin Infect Dis. 2022 doi: 10.1093/cid/ciac553. Epub ahead of print. PMID: 35788276; PMCID: PMC9278259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac553</ArticleId><ArticleId IdType="pmc">PMC9278259</ArticleId><ArticleId IdType="pubmed">35788276</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Perramon A., Catal&#xe0; M., et al. COPEDI-CAT Research Group Multisystem inflammatory syndrome in children in western countries? Decreasing incidence as the pandemic progresses?: an observational multicentre international cross-sectional study. Pediatr Infect Dis J. 2022;41(12):989&#x2013;993. doi: 10.1097/INF.0000000000003713. Epub 2022 Oct 21. PMID: 36102705; PMCID: PMC9645445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003713</ArticleId><ArticleId IdType="pmc">PMC9645445</ArticleId><ArticleId IdType="pubmed">36102705</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the RealWorld: a systematic review and meta-analysis. Int J Environ Res Publ Health. 2022;19 doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53 doi: 10.1016/j.eclinm.2022.101624. PMID: 36051247; PMCID: PMC9417563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H., AlMukdad S., Ayoub H.H., et al. Covid-19 vaccine protection among children and adolescents in Qatar. N&#xa0;Engl J Med. 2022;387(20):1865&#x2013;1876. doi: 10.1056/NEJMoa2210058. Epub 2022 Nov 2. PMID: 36322837; PMCID: PMC9644642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2210058</ArticleId><ArticleId IdType="pmc">PMC9644642</ArticleId><ArticleId IdType="pubmed">36322837</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Buonsenso D., Sigfrid L., Vijverberg S.J.H., Brackel C.L.H. Post-COVID-19 condition in children: a COS is urgently needed. Lancet Respir Med. 2022;10(7):628&#x2013;629. doi: 10.1016/S2213-2600(22)00211-9. Epub 2022 Jun 14. PMID: 35714657; PMCID: PMC9197248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00211-9</ArticleId><ArticleId IdType="pmc">PMC9197248</ArticleId><ArticleId IdType="pubmed">35714657</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeser C., Whitaker H., Borrow R., et al. Following the Omicron wave, the majority of children in England have evidence of previous COVID infection. J&#xa0;Infect. 2022;(22):S0163&#x2013;S4453. doi: 10.1016/j.jinf.2022.12.012. Epub ahead of print. PMID: 36543312; PMCID: PMC9759455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.12.012</ArticleId><ArticleId IdType="pmc">PMC9759455</ArticleId><ArticleId IdType="pubmed">36543312</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>